Valneva SE (VALN) Change in Working Capital (2021 - 2026)

Valneva SE (VALN) posted quarterly Change in Working Capital of $19.6 million for Q1 2026, up 287.73% year-on-year from $5.1 million in Q1 2025, and up 16349.06% on a QoQ basis from -$120623.2 in Q4 2025.

Valneva SE (VALN) Change in Working Capital (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Change in Working Capital for 6 consecutive years, with $19.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Working Capital rose 287.73% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.7 million (up 112.07% YoY) and the FY2025 annual result came in at $1.7 million, down 87.09% from the prior year.
  • Change in Working Capital climbed to $19.6 million in Q1 2026 per VALN's latest filing, from -$120623.2 in the prior quarter.
  • Over the last five years, Change in Working Capital for VALN reached as high as $48.6 billion in Q3 2023 and fell as low as -$48.7 billion in Q2 2023.
  • A 5-year average of $11.6 million and a median of -$120623.2 in 2025 frame the typical range for Change in Working Capital.
  • The largest YoY upside for Change in Working Capital was 38763.39% in 2023 against a maximum downside of 28988.81% in 2023.
  • Year by year, Change in Working Capital stood at -$57.5 million in 2022, then soared by 572.51% to $271.9 million in 2023, then tumbled by 80.55% to $52.9 million in 2024, then sank by 100.23% to -$120623.2 in 2025, then soared by 16349.06% to $19.6 million in 2026.
  • According to Business Quant data, Change in Working Capital over the past three periods registered $19.6 million, -$120623.2, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 19.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.60 Mn
Mar 31, 2026 19.60 Mn
Dec 31, 2025 -120,623.15
Dec 31, 2025 -120,623.15
Sep 30, 2025 10.66 Mn
Sep 30, 2025 10.66 Mn
Jun 30, 2025 1.58 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 -10.44 Mn
Mar 31, 2025 -10.44 Mn
Dec 31, 2024 52.88 Mn
Dec 31, 2024 52.88 Mn
Sep 30, 2024 -4.46 Mn
Sep 30, 2024 -4.46 Mn
Jun 30, 2024 -23.02 Mn
Jun 30, 2024 -23.02 Mn
Mar 31, 2024 -12.43 Mn
Mar 31, 2024 -12.43 Mn
Dec 31, 2023 271.87 Mn
Dec 31, 2023 271.87 Mn